Your session is about to expire
← Back to Search
Telehealth Smoking Cessation for Quitting Smoking (E-STOP Trial)
E-STOP Trial Summary
This trial is testing whether an electronic visit (e-visit) for smoking cessation is effective. Participants will be assigned at random to either receive the e-visit or not. The e-visit will be in the form of an online questionnaire about smoking history, motivation to quit, and preferences for quitting medications. If participants are randomized to the e-visit group, they may receive a prescription for a smoking cessation medication, but they are not required to take it. The study will last 24 weeks and consist of four time points where participants will answer questionnaires and provide breath samples.
E-STOP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.E-STOP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I check my email daily with a valid email address.You need to have an iOS or Android smartphone to participate in the study and provide remote carbon monoxide readings.I have used a quit-smoking medication approved by the FDA in the past week.I am 18 years old or older.I am enrolled in MyChart or willing to sign up.You have been smoking 5 or more cigarettes per day for at least 6 months out of the last 30 days.
- Group 1: Smoking cessation electronic visit (e-visit)
- Group 2: Treatment as usual (TAU)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this trial still being accepted?
"This research initiative, published on August 31st 2022, is still recruiting participants. The information was recently updated on November 15th 2022."
What is the upper-limit of individuals involved in this research?
"Correct. According to the clinicaltrials.gov, this medical examination is actively looking for participants since its introduction on August 31st 2022 and most recent update in November 15th 2022. A total of 672 patients are required across one location."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger